ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.
ConditionICU Acquired Weakness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorEndeavor Health
About this trial
This study is testing whether a non-invasive nerve monitoring device (TetraGraph) can accurately detect early signs of ICU-acquired weakness by comparing readings from the device with standard nerve conduction/EMG tests done by a specialist to see if they match. They will focus on muscle response signals in the hand and leg over about 10 days in three groups: healthy volunteers, ICU patients who are not on ventilators, and ICU patients who are on ventilators.
Eligibility criteria
Qualifiers
Cohort 1: Healthy volunteers
Subjects must be > 18 years old and < 90 years old.
Subjects must consent to participate. Cohort 2: Non-intubated critically ill patients
Subjects may be male or female.
Disqualifiers
Cohort 1: Healthy volunteers
Subjects with previous paralysis or neuromuscular disease.
Subjects with spinal cord or brain injuries that impact motor function.
Subjects with an allergy to clinical adhesive or hydrogel. Cohort 2: Non-intubated critically ill patients
Trial design
Treatments tested in this trial
- TetraGraph
- Electromyography
- Nerve conduction studies
Treatment groups
24 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov